ClinicalTrials.Veeva

Menu

Use of Hyaluronic Acid as a Therapeutic Strategy for Bone Repair in Human

F

Federal University of Minas Gerais

Status and phase

Completed
Phase 2
Phase 1

Conditions

Alveolar Bone Loss

Treatments

Drug: hyaluronic acid
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT02709525
CAAE: 0328.0.203.000-10

Details and patient eligibility

About

The aim of this study is to evaluate the effects of hyaluronic acid (HA) on bone healing in human dental sockets.

Enrollment

16 patients

Sex

All

Ages

14 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Orthodontic need for bilateral extraction of lower first premolars

Exclusion criteria

  • Alcoholism, smoking, drug use and abuse of drugs; Systemic diseases: uncontrolled diabetes, blood dyscrasias, kidney or heart failure and osteoporosis; clinical or radiographic signs of pathological processes in the bone;

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

16 participants in 2 patient groups, including a placebo group

hyaluronic acid
Experimental group
Description:
Immediately after the extractions, one socket was randomly filled with 1% hyaluronic acid gel.
Treatment:
Drug: hyaluronic acid
Blood clot
Placebo Comparator group
Description:
Immediately after the extractions, the other side socket was naturally filled with blood clot.
Treatment:
Other: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems